A fourth strong contender appears to have emerged for COVID-19 vaccines in the United States, as this week’s results from the Phase 3 PREVENT-19 trial of the Novavax, Inc. COVID-19 demonstrated a 90 percent overall efficacy against the disease.
The NVX-CoV2373 vaccine fully protected against... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will provide $706,534 in funding for Dascena, Inc. to further its COViage system, potentially expanding its machine learning capabilities to predict deteriorating health among hospitalized COVID-19 patients.
Hospitalized COVID-19... Read More »
On Wednesday, U.S. Sens. Jeff Merkley (D-OR) and Elizabeth Warren (D-MA) joined U.S. Reps. Raja Krishnamoorthi (D-IL) and Suzanne Bonamici (D-OR) to introduce legislation that would expand the U.S. response to the coronavirus on an international level.
The Nullifying Opportunities for Variants... Read More »
In efforts to improve the Strategic National Stockpile, the U.S. Department of Health and Human Services (HHS) awarded a $53.4 million contract to Henry Schein, Inc. this week for the storage and distribution of 80,000 pallets of personal protective equipment and COVID-19 related products.
This... Read More »
A new study from the Centers for Disease Control and Prevention (CDC) demonstrated continuing good news for mRNA COVID-19 vaccines, crediting them with reducing the risk of infection by 91 percent for those fully vaccinated by either the Pfizer-BioNTech or Moderna vaccines.
While previous... Read More »
In a letter to President Joe Biden last week, more than 40 U.S. representatives sought to use the impending G7 Summit as an opportunity to call for five quick, immediate actions to guarantee COVID-19 vaccines were administered worldwide.
The group, led by U.S. Reps. Pramila Jayapal (D-WA), Tom... Read More »
The newest White House budget proposal would put billions of dollars in funding toward public health, drug, and research initiatives, offering what the Infectious Diseases Society of America (IDSA) called the potential to return the United States to leadership in infectious disease responses.
At... Read More »
With $4.2 million in funding from the Henry Jackson Foundation and a new partnership with the U.S. Naval Medical Research Center (NMRC), Centivax Inc. intends to pursue phase one clinical development of Centi-B9, a broad-spectrum injectable for treating SARS-CoV-2.
Unlike other vaccines and... Read More »
The leaders of the international organizations for financing, health, and trade are urging government leaders to finance a new $50 billion roadmap to help end the pandemic and spur global economic recovery.
Leaders of the International Monetary Fund, World Bank Group, World Health Organization,... Read More »
U.S. Reps. Brian Fitzpatrick (R-PA) and Conor Lamb (D-PA) sought legislative action on foreign nations’ health efforts last week, introducing the Never Again International Outbreak Prevention Act to establish new monitoring and reporting mandates, sanctions, and an investigation of the World... Read More »
President Joe Biden’s first budget proposal would authorize the largest funding increase in nearly two decades for the Centers for Disease Control and Prevention (CDC), going above and beyond funding the agency’s disease-focused work at the U.S. Department of Health and Human Services... Read More »
According to the World Health Organization (WHO), the COVID-19 pandemic situation is stabilizing in nations with advanced vaccination programs, but it is surging in other, less equipped areas, demanding action lest the future become a repeat of present failures.
WHO urges the distribution of 2... Read More »
The U.S. Food and Drug Administration (FDA) added another tool to the fight against COVID-19 this week, granting emergency use authorization (EUA) to the monoclonal antibody therapy sotrovimab for use against mild to moderate COVID-19 cases in those 12 years and older.
The EUA was granted to... Read More »
Thanks to a $400,000 grant from The Rockefeller Foundation, the Johns Hopkins Center for Health Security will document, evaluate and spread information on large-scale health successes among the COVID-19 response in low and middle-income nations over the past year.
This information will be used... Read More »
Academia and the private sector must be in a collaborative relationship with the United States government to invest in the research and development of technologies that will prevent a future pandemic, experts said on Wednesday during a webinar hosted by the Capitol Hill Steering Committee on... Read More »
Plans are underway to submit the Moderna, Inc. COVID-19 vaccine to regulators in early June to expand its use, following positive results from a Phase 2/3 study that distributed the vaccine among adolescents aged 12 to 17 years old.
The vaccine, known as mRNA-1273, met its primary immunogenicity... Read More »
In a letter to Homeland Security Secretary Alejandro Mayorkas written last week, Republican House Energy and Commerce Committee leaders requested two classified briefings on the origins of COVID-19 and any work conducted therein.
“[W]e strongly support a comprehensive investigation into the... Read More »
With the reintroduction of the Medical Supplies for Pandemics Act in the Senate last week, U.S. Sens. Thom Tillis (R-NC) and Michael Bennet (D-CO) sought to more tightly link the federal government and medical product distributors to strengthen domestic manufacturing and refill the Strategic... Read More »
In the wake of a pandemic response that had been hobbled initially by a lack of domestic medical supplies and an overreliance on foreign supply chains, Senate Homeland Security and Governmental Affairs Committee Chairman Gary Peters (D-MI) held an oversight hearing with supply chain,... Read More »
Up to $4.1 million in non-dilutive funding from nonprofit CARB-X was announced this week for Summit Therapeutics to help develop a first-in-class antibiotic to treat multidrug-resistant infections, and specifically, carbapenem-resistant Enterobacteriaceae (CRE) infections.
This funding will aid... Read More »
Across all adult age groups, going as high as 95 years old, a phase two trial of the Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate has demonstrated high antibody responses and no safety concerns, according to interim data released this week.
Strong immune responses included a... Read More »
The Defense Logistics Agency (DLA) recently awarded a $100,000 contract to Charles River Analytics for the creation of a means to assemble information from global trade networks and pharmaceutical drug data and present it in a way that would allow quick identification of problems in the supply... Read More »
The results of a real-world Centers for Disease Control and Prevention (CDC) study of 1,843 health workers across the United States showed last week that COVID-19 mRNA vaccines authorized by the U.S. Food and Drug Administration (FDA) are 94 percent effective.
Currently approved mRNA vaccines... Read More »
In a public statement released last week, nine national organizations highlighted the pains COVID-19 inflicted upon the world in general and already historically marginalized populations in specific and pressed for strategies to improve crisis standards of care, along with equity.
“The... Read More »
Seven U.S. representatives introduced the State and Local Cybersecurity Improvement Act this week, which seeks to authorize a new Department of Homeland Security (DHS) grant program to fund local and state cybersecurity efforts.
In all, the program would benefit from $500 million in funding to... Read More »
Leaders of the House Energy and Commerce Committee and subcommittees wrote to Health and Human Services (HHS) Secretary Xavier Becerra this week urging a reversal of a Trump administration policy that stripped Food and Drug Administration (FDA) authority over COVID-19 lab-developed tests (LDTs).... Read More »
The U.S. Food and Drug Administration (FDA) announced Monday that the Pfizer-BioNTech vaccine is now authorized for emergency use among adolescents ages 12 through 15.
While children have seemingly been less susceptible to COVID-19 at large, they can still be carriers, and plenty have... Read More »
America’s historically underfunded public health system played a major role in the nation’s laggard COVID-19 response, according to a new report released by the Trust for America’s Health (TFAH).
And while it’s too soon to calculate with precision, it is likely that the United States... Read More »
The World Health Organization (WHO) added the Sinopharm COVID-19 vaccine produced by Beijing Bio-Institute of Biological Products Co Ltd. to the list of vaccines approved for emergency use worldwide last week, giving a potential new source and new boost for efforts by the COVAX... Read More »
Bloomberg Philanthropies will award up to $50,000 each to 18 cities in low and middle-income countries that are part of the Partnership for Healthy Cities and planning vaccine distribution rollouts with high-risk populations emphasized.
Vaccine preparedness activities, including communication... Read More »
Moderna, Inc. reported initial data this week showing that in phase two testing, its mRNA COVID-19 vaccine proved effective and well-tolerated as a booster or a single 50 µg dose on the previously vaccinated, against both the original SARS-CoV-2 strain and two variants of concern.
In all, three... Read More »
U.S. Sens. Mark Warner (D-VA) and Tim Kaine (D-VA), as well as Ben Cardin (D-MD) and Chris Van Hollen (D-MD), are urging President Joe Biden to resume the process of selecting a new home for the Federal Bureau of Investigation.
In a letter to the Biden administration, the four Congressmen... Read More »
President Joe Biden announced Tuesday a new federal goal to get at least one COVID-19 vaccine shot in 70 percent of the U.S. adult population and 160 million adults fully vaccinated by July 4, 2021.
Accessibility is the main focus in the next leg of the vaccination effort. To that end, the... Read More »
Responding to the spiraling COVID-19 situation in India, Pfizer Inc. announced this week that it will provide more than $70 million worth of medicines to the country immediately, with assistance from government and non-governmental organization partners.
“We are donating enough medicines to... Read More »
The global COVAX initiative received a major boost in its fight against COVID-19 this week through a new deal with Moderna, Inc. that will bring up to 500 million doses of vaccine into the fold for use by the lowest income countries, including up to 34 million doses this year alone.
Delivery of... Read More »